Advertisement

Skin Diseases from Metabolic, Endocrinologic Diseases

  • Franco RongiolettiEmail author

Abstract

Endocrine diseases are any diseases caused by the abnormal function of endocrine glands, including the adrenal, pituitary, thyroid, and parathyroid glands. Metabolic disorders involve the disruption of metabolic processes and are caused by genetic errors, hormonal dysfunction, and/or mineral or vitamin deficiency states. Common metabolic disorders include diabetes, hyperlipoproteinemia, and obesity.

Abbreviations

ACTH

Adrenocorticotropic hormone

APECED

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

DD

Diabetic dermopathy

FSH

Follicle-stimulating hormone

GA

Granuloma annulare

GH

Growth hormone

HMG-CoA

Hydroxy-methylglutaryl coenzyme A

IGF-1

Insulin-like growth factor 1

LH

Luteinizing hormone

MEN1

Multiple endocrine neoplasia type 1

NL

Necrobiosis lipoidica

PTH

Parathyroid hormone

TSH-(R)

Thyroid-stimulating hormone (receptor)

TSI

Thyroid-stimulating immunoglobulin

References

  1. Hahler B. An overview of dermatological conditions commonly associated with the obese patient. Ostomy Wound Manag. 2006;52:34–6.Google Scholar
  2. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141:1527–34.CrossRefGoogle Scholar

Further Reading

  1. Adams DR, Gordon KB, Devenyi AG, Ioffreda MD. Severe hidradenitis suppurativa treated with infliximab infusion. Arch Dermatol. 2003;139:1540–2.CrossRefGoogle Scholar
  2. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol. 2006;24:237–46.CrossRefGoogle Scholar
  3. Alkofer B, Chiche L, Khayat A, Deshayes J, Lepage A, Saloux E, Reznik Y. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant Proc. 2005;37:2250–2.CrossRefGoogle Scholar
  4. Anderson CK, Miller 3rd OF. Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves’ disease. J Am Acad Dermatol. 2003;48:970–2.CrossRefGoogle Scholar
  5. Artantaş S, Gül U, Kiliç A, Gűler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;20:158–61.CrossRefGoogle Scholar
  6. Barde C, Masouyé I, Saurat JH, Le Gal FA. Scleroedema adultorum Buschke in a diabetic subject: intravenous immunoglobulin therapy. Ann Dermatol Venereol. 2009;136:360–3.CrossRefGoogle Scholar
  7. Barouti N, Qian Cao A, Ferrara D, Prins C. Successful treatment of ulcerative and diabeticorum necrobiosis lipoidica with intravenous immunoglobulin in a patient with common variable immunodeficiency. JAMA Dermatol. 2013;149:879–81.CrossRefGoogle Scholar
  8. Ben-Shlomo A, Melmed S. Skin manifestations in acromegaly. Clin Dermatol. 2006;24:256–9.CrossRefGoogle Scholar
  9. Birtane M, Tuna H, Birtane M, Tuna H. The evaluation of plantar pressure distribution in obese and non-obese adults. Clin Biomech. 2004;19:1055–9.CrossRefGoogle Scholar
  10. Borlu M, Tanriverdi F, Koc CA, et al. The effects of severe growth hormone deficiency on the skin of patients with Sheehan’s syndrome. J Eur Acad Dermatol Venereol. 2006;21:199–204.Google Scholar
  11. Burman KD, McKinley-Grant L. Dermatologic aspects of thyroid disease. Clin Dermatol. 2006;24:247–55.CrossRefGoogle Scholar
  12. Burnside N, Alberta L, Robinson-Bostom L, Bostom A. Type III hyperlipoproteinemia with xanthomas and multiple myeloma. J Am Acad Dermatol. 2005;53:S281–4.CrossRefGoogle Scholar
  13. Callen J. Dermatologic signs of systemic disease. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. New York: Mosby; 2003. p. 718–9.Google Scholar
  14. Collier F, Smith RC, Morton CA. Diagnosis and management of hidradenitis suppurativa. BMJ. 2013;346:f2121.CrossRefGoogle Scholar
  15. Cruz P, East C, Bergstressor P. Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 1988;19:95–111.CrossRefGoogle Scholar
  16. Davidovici BB, Orion E, Wolf R. Cutaneous manifestations of pituitary gland diseases. Clin Dermatol. 2008;26:288–95.CrossRefGoogle Scholar
  17. Dembowski E, Davidson M. A review of lipid management in primary and secondary prevention. J Cardiopulm Rehabil Prev. 2009;29:2–12.CrossRefGoogle Scholar
  18. Dhaille F, Dadban A, Meziane L, Fessier C, Colta L, Lok C, Chaby G. Elephantiasic pretibial myxoedema with upper-limb involvement, treated with low-dose intravenous immunoglobulins. Clin Exp Dermatol. 2012;37:307–8.CrossRefGoogle Scholar
  19. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. 2004;350:2068–79.CrossRefGoogle Scholar
  20. el-Azhary RA, Arthur AK, Davis MD, McEvoy MT, Gibson LE, Weaver AL, Camilleri MJ, Wetter DA, Weenig RH. Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis. JAMA Dermatol. 2013;149:63–7.CrossRefGoogle Scholar
  21. Fatourechi V. Thyroid dermopathy and acropachy. Best Pract Res Clin Endocrinol Metab. 2012;26:553–65.CrossRefGoogle Scholar
  22. Fuleihan G-H, Rubeiz N. Dermatologic manifestations of parathyroid-related disorders. Clin Dermatol. 2006;24:281–8.CrossRefGoogle Scholar
  23. Garcia Hidalgo L, Garcia HL. Dermatological complications of obesity. Am J Clin Dermatol. 2002;3:497–506.CrossRefGoogle Scholar
  24. Geller JL, Braunstein GD. Dermatologic manifestations in hypopituitarism. Clin Dermatol. 2006;24:266–75.CrossRefGoogle Scholar
  25. Ghosh Y, Pradhan E, Ahluwalia H. Excision of xanthelasmata – clamp, shave, and suture. Int J Dermatol. 2009;48:181–3.CrossRefGoogle Scholar
  26. Goldberg DJ, Sarradet D, Hussain M, Goldberg DJ, Sarradet D, Hussain M. 308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol Surg. 2003;29:596–8.PubMedGoogle Scholar
  27. Hu SW, Bevona C, Winterfield L, Qureshi AA, Li VW. Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case. Arch Dermatol. 2009;145:437–9.PubMedGoogle Scholar
  28. Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003;4:315–31.CrossRefGoogle Scholar
  29. Jabbour SA, Miller JL. Endocrinopathies and the skin. Int J Dermatol. 2000;39:88–99.CrossRefGoogle Scholar
  30. Jemec GB. Medical treatment of hidradenitis suppurativa. Expert Opin Pharmacother. 2004;5:1767–70.CrossRefGoogle Scholar
  31. Jimenez GP, Flores F, Berman B, et al. Treatment of striae rubra and striae alba with the 585-nm pulsed-dye laser. Dermatol Surg. 2003;29:362–5.PubMedGoogle Scholar
  32. Katz TM, Goldberg LH, Friedman PM. Fractional photothermolysis: a new therapeutic modalities for xanthelasma. Arch Dermatol. 2009;145:1091–4.CrossRefGoogle Scholar
  33. Kroft EB, de Jong EM. Scleredema diabeticorum case series: successful treatment with UV-A1. Arch Dermatol. 2008;144:947–8.PubMedGoogle Scholar
  34. Marais A, Firth J, Blom D. Homozygous familial hypercholesterolemia and its management. Semin Vasc Med. 2004;4:43–50.CrossRefGoogle Scholar
  35. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2001;344:240, 696.Google Scholar
  36. Mattar M, Obeid O. Fish oil and the management of hypertriglyceridemia. Nutr Health. 2009;20:41–9.CrossRefGoogle Scholar
  37. Mukhtar M. Surgical pearl: tissue forceps as a simple and effective instrument for treating skin tags. Int J Dermatol. 2006;45:577–9.CrossRefGoogle Scholar
  38. Ngo BT, Hayes KD, DiMiao DJ, Srinivasan SK, Huerter CJ, Rendell MS. Manifestations of cutaneous diabetic microangiopathy. Am J Clin Dermatol. 2005;6:225–23.CrossRefGoogle Scholar
  39. Nieman LK, Chanco Turner ML. Addison’s disease. Clin Dermatol. 2006;24:276–80.CrossRefGoogle Scholar
  40. Ortega-Gonzalez C, Luna S, Hernandez L, et al. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1360–5.CrossRefGoogle Scholar
  41. Oumeish OY. Skin disorders in patients with diabetes. Clin Dermatol. 2008;26:235–42.CrossRefGoogle Scholar
  42. Parker F. Xanthomas and hyperlipidemias. J Am Acad Dermatol. 1985;13:1–30.CrossRefGoogle Scholar
  43. Piaserico S, Zattra E, Linder D, Peserico A. Generalized granuloma annulare treated with methylaminolevulinate photodynamic therapy. Dermatology. 2009;218:282–4.CrossRefGoogle Scholar
  44. Rongioletti F, Smoller BR. Clinical and pathological aspects of skin diseases in endocrine, metabolic, nutritional and deposition disease. New York: Springer; 2010.Google Scholar
  45. Rosmarin D, LaRaia A, Schlauder S, Gottlieb AB. Successful treatment of disseminated granuloma annulare with adalimumab. J Drugs Dermatol. 2009;8:169–71.PubMedGoogle Scholar
  46. Schneider JB, Norman RA. Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly. Dermatol Clin. 2004;22:23–31.CrossRefGoogle Scholar
  47. Shibli-Rahhal A, Van Beek M, Schlechte JA. Cushing’s syndrome. Clin Dermatol. 2006;24:260–5.CrossRefGoogle Scholar
  48. Siddi G, Pes G, Errigo A, Corraduzza G, Ena P. Multiple tuberous xanthomas as the first manifestation of autosomal recessive hypercholesterolemia. J Eur Acad Dermatol Venereol. 2006;20:1376–13781.CrossRefGoogle Scholar
  49. Souza AD, El-Azhary RA, Gibson LE. Does pancreas transplant in diabetic patients affect the evolution of necrobiosis lipoidica? Int J Dermatol. 2009;48:964–70.CrossRefGoogle Scholar
  50. Tankova T, Koev D, Dakovska L, Kirilov G. Therapeutic approach in insulin resistance with acanthosis nigricans. Int J Clin Pract. 2002;56:578–81.PubMedGoogle Scholar
  51. Todd DJ, Eedy DJ, McMillan JC. Acromegaly and psoriasis. Clin Exp Dermatol. 1991;16:222–3.CrossRefGoogle Scholar
  52. Van Hattem S, Bootsma AH, Thio HB. Skin manifestations of diabetes. Cleve Clin J Med. 2008;75:772–87.CrossRefGoogle Scholar
  53. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002;15:172–86.CrossRefGoogle Scholar
  54. Wollina U. Update on cutaneous calciphylaxis. Indian J Dermatol. 2013;58:87–92.CrossRefGoogle Scholar
  55. Yosipovitch G, DeVore A, Dawn A, Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56:901–16.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.DISSALUniversity of GenovaGenoaItaly

Personalised recommendations